Sign in

CIK 0001133869

  • Non-accelerated filer
  • Smaller reporting company

CAPRICOR THERAPEUTICS, INC.

Sign in to watch
Ticker
CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 310-358-3200
Business address
10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
Former names
Nile Therapeutics, Inc., SMI PRODUCTS INC
  1. 4 Open-market buy Chief Financial Officer bought 3,814 shares at an average $0.75 ($2,870)
  2. 4 Open-market buy Director bought 4,000 shares at $0.69 ($2,767)
  3. 4 Open-market buy Chief Executive Officer bought 3,580 shares at $0.60 ($2,158)
  4. 4 Open-market buy Director bought 100 shares at $4.60 ($460)
  5. 4 Open-market buy Chief Financial Officer bought 800 shares at an average $4.55 ($3,640)
  6. 4 Open-market buy Chief Executive Officer bought 1,400 shares at $4.70 ($6,580)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 17 of 18 · 345 filings